A lot to like about this one - not as sexy as some medical companies products or potential subject to subject to subject trials products
By contrast RNV has one product already in place with full US approval's and already being used/sold and a clear pipeline for 2 other very good products to be approved in good/quick time
A slow burner but looks like a very good story (DYOR off course)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.020(20.0%) |
Mkt cap ! $13.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 12.0¢ | 10.0¢ | $9.015K | 80.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56000 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 147679 | 5 |
View Market Depth
| Last trade - 16.13pm 28/07/2025 (20 minute delay) ? |
| RNV (ASX) Chart |